Merck Serono, the biopharmaceutical division of Merck, is the founding supporter of the newly launched Multiple Sclerosis (MS) Resource Centre website developed by Elsevier, B.V. of the Netherlands. Merck Serono helped established the MS Resource Centre through a $250,000 unrestricted grant to Elsevier, B.V. to develop and launch the website, which will provide high quality, balanced and scientifically valid information to health care providers.
“Merck Serono is proud to have provided the necessary foundation for Elsevier to develop this website that aims to provide clinicians with access to the latest literature on multiple sclerosis,” said Thorsten Eickenhorst, senior vice president and chief medical officer at EMD Serono Inc., a subsidiary of Merck. “We are committed to supporting organizations that invest in the understanding and treatment of multiple sclerosis, and share our goal of improving patient care.”
The MS Resource Centre is a medical education platform for healthcare providers hosted by Elsevier’s new peer-reviewed journal, Multiple Sclerosis and Related Disorders. This website will afford the MS community numerous benefits, including access to taped lectures, video interviews with leaders in the field, a congress planner and key articles reporting on breakthrough findings by highly regarded authors. Timothy Vartanian, professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell University is the editor of the Resource Center.
The site will be launched at the ECTRIMS 2013 conference, Oct. 2 to 5, in Copenhagen, Denmark.
Date: October 1, 2013
Source: Merck KGaA
Filed Under: Drug Discovery
